LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,000 | -29.2% | 2,654 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | -54.7% | 2,654 | 0.0% | 0.00% | – |
| Q3 2018 | $53,000 | -31.2% | 2,654 | 0.0% | 0.00% | – |
| Q2 2018 | $77,000 | -2.5% | 2,654 | 0.0% | 0.00% | – |
| Q1 2018 | $79,000 | -7.1% | 2,654 | 0.0% | 0.00% | – |
| Q4 2017 | $85,000 | -6.6% | 2,654 | 0.0% | 0.00% | – |
| Q3 2017 | $91,000 | +15.2% | 2,654 | 0.0% | 0.00% | – |
| Q2 2017 | $79,000 | 0.0% | 2,654 | 0.0% | 0.00% | – |
| Q1 2017 | $79,000 | +68.1% | 2,654 | 0.0% | 0.00% | – |
| Q4 2016 | $47,000 | -62.7% | 2,654 | -50.0% | 0.00% | – |
| Q3 2016 | $126,000 | +200.0% | 5,308 | +100.0% | 0.00% | – |
| Q2 2016 | $42,000 | -23.6% | 2,654 | 0.0% | 0.00% | – |
| Q1 2016 | $55,000 | -23.6% | 2,654 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000 | – | 2,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 240,000 | $1,116,000 | 99.38% |
| TANG CAPITAL MANAGEMENT LLC | 9,607,934 | $44,677,000 | 8.98% |
| HealthInvest Partners AB | 830,000 | $3,860,000 | 5.44% |
| RTW INVESTMENTS, LP | 2,327,903 | $10,825,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 185,598 | $864,000 | 0.09% |
| WealthTrust Axiom LLC | 25,400 | $118,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 82,355 | $383,000 | 0.03% |
| FIRST MIDWEST BANK TRUST DIVISION | 41,731 | $194,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 435,387 | $2,023,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 17,176 | $80,000 | 0.01% |